
Astra Zeneca has announced a research programme to develop a generation of medicines to treat the genetic causes of many debilitating diseases. It will be the first concerted use of an emerging technique called Crispr to "snip out" specific disease genes in order to discover drugs. via Pocket http://ift.tt/1yBykPq
No comments:
Post a Comment